▁Sky 9.2109375
e 3.3125
Ph 7.48828125
arma 0.861328125
▁Pred 9.40625
ict 0.1895751953125
s 0.07855224609375
▁" 5.33203125
Mag 9.578125
ic 0.37744140625
▁Year 1.8271484375
" 0.051666259765625
▁of 3.5390625
▁G 2.08984375
row 0.039520263671875
th 0.002346038818359375
▁for 3.169921875
▁In 3.87890625
vest 5.9453125
ors 0.019866943359375
▁in 3.28125
▁ 0.27001953125
1 1.8603515625
9 0.0080413818359375
9 0.0092620849609375
8 1.3369140625
<0x0A> 0.1944580078125
L 4.58984375
ON 0.462158203125
D 0.0004177093505859375
ON 0.00017726421356201172
▁— 5.3984375
▁Sky 0.72509765625
e 0.00970458984375
Ph 0.10919189453125
arma 0.0009279251098632812
, 1.8583984375
▁a 1.2646484375
▁leading 3.203125
▁global 5.08203125
▁drug 2.94921875
▁delivery 1.220703125
▁company 0.279541015625
, 0.26806640625
▁is 2.33203125
▁predict 0.806640625
ing 0.0003459453582763672
▁a 0.7470703125
▁" 0.76806640625
mag 0.06640625
ic 0.0159149169921875
▁year 0.060089111328125
" 0.045440673828125
▁of 0.61962890625
▁growth 0.297119140625
▁for 0.4697265625
▁its 1.4462890625
▁invest 0.8837890625
ors 0.00299835205078125
▁in 0.308837890625
▁ 0.01354217529296875
1 0.0008411407470703125
9 5.7220458984375e-05
9 8.797645568847656e-05
8 0.0016317367553710938
, 1.275390625
▁driven 3.822265625
▁by 0.09454345703125
▁a 2.169921875
▁robust 4.57421875
▁product 2.32421875
▁pipeline 0.4267578125
▁and 0.765625
▁strateg 5.18359375
ic 0.045318603515625
▁partners 1.5732421875
hips 0.07305908203125
. 0.712890625
▁With 5.11328125
▁innov 6.359375
ative 0.1456298828125
▁drug 1.916015625
▁delivery 0.2156982421875
▁techn 1.158203125
ologies 0.0012722015380859375
▁and 1.982421875
▁a 1.50390625
▁strong 1.7099609375
▁financial 3.10546875
▁performance 3.140625
, 0.385498046875
▁the 0.88525390625
▁company 0.343994140625
▁is 0.7490234375
▁po 2.59765625
ised 0.0007424354553222656
▁to 0.45751953125
▁capital 2.71875
ize 0.12005615234375
▁on 0.0186614990234375
▁emer 4.015625
ging 0.003650665283203125
▁tr 2.630859375
ends 0.0009298324584960938
▁in 0.346923828125
▁the 0.484375
▁ph 0.6435546875
arma 0.00191497802734375
ce 0.0096588134765625
ut 6.031990051269531e-05
ical 0.0004870891571044922
▁industry 0.292236328125
. 0.62060546875
<0x0A> 0.189453125
S 1.1015625
ky 0.00855255126953125
e 0.0006403923034667969
Ph 0.0164337158203125
arma 0.0010318756103515625
' 0.91357421875
s 0.00027871131896972656
▁vision 5.88671875
▁for 2.7421875
▁growth 2.5625
▁was 5.5625
▁out 1.4189453125
lined 7.76052474975586e-05
▁during 3.40625
▁a 1.0537109375
▁recent 1.2431640625
▁presentation 1.892578125
▁to 1.15234375
▁invest 0.6201171875
ors 0.0185699462890625
. 2.38671875
▁CE 4.15625
O 0.00041365623474121094
▁Jer 5.21484375
emy 0.34912109375
▁Ha 8.3515625
igh 0.7177734375
▁highlight 1.7314453125
ed 0.0014619827270507812
▁the 0.231201171875
▁company 0.13427734375
' 0.0061187744140625
s 4.935264587402344e-05
▁achiev 4.51171875
ements 0.00424957275390625
▁in 0.890625
▁ 0.90771484375
1 0.10064697265625
9 0.00036263465881347656
9 0.00023233890533447266
7 0.0284271240234375
, 0.376220703125
▁including 0.4580078125
▁the 0.751953125
▁ac 2.673828125
quisition 0.0281982421875
▁of 0.008544921875
▁drug 5.2734375
▁delivery 0.158935546875
▁special 2.822265625
ist 0.14990234375
▁Ari 10.296875
us 1.7880859375
▁Ph 1.12109375
arma 0.0030345916748046875
ce 0.4453125
ut 8.869171142578125e-05
ical 0.0002510547637939453
s 0.0718994140625
▁and 0.80810546875
▁se 6.10546875
cur 0.00804901123046875
ing 0.0002772808074951172
▁multiple 4.69140625
▁lic 2.0546875
ens 0.046478271484375
ing 5.173683166503906e-05
▁de 1.1318359375
als 2.0384788513183594e-05
▁with 1.1640625
▁major 1.009765625
▁ph 0.07568359375
arma 0.0002353191375732422
ce 0.0193328857421875
ut 1.0371208190917969e-05
ical 2.2649765014648438e-05
▁companies 0.1683349609375
. 0.1236572265625
▁He 1.9169921875
▁also 0.31787109375
▁emphas 1.5185546875
ized 0.005023956298828125
▁the 0.2210693359375
▁immense 8.8125
▁potential 0.1832275390625
▁of 0.1221923828125
▁the 0.96728515625
▁company 0.09710693359375
' 0.002468109130859375
s 2.3603439331054688e-05
▁innov 3.4140625
ative 0.0085296630859375
▁techn 1.771484375
ologies 0.0006022453308105469
▁in 3.443359375
▁en 4.33203125
han 0.1622314453125
cing 3.814697265625e-06
▁the 0.291259765625
▁effic 1.05859375
acy 0.0003039836883544922
▁and 0.26171875
▁safety 0.4404296875
▁of 0.00965118408203125
▁existing 1.3408203125
▁dru 0.45947265625
gs 4.0531158447265625e-06
. 0.84521484375
<0x0A> 0.09783935546875
The 2.044921875
▁corner 8.5078125
stone 0.01336669921875
▁of 0.0050811767578125
▁Sky 0.08203125
e 0.00013363361358642578
Ph 0.0015115737915039062
arma 0.00047087669372558594
' 0.0013551712036132812
s 7.069110870361328e-05
▁success 2.83984375
▁lies 1.146484375
▁in 0.00373077392578125
▁its 0.07232666015625
▁port 4.5625
folio 0.0004944801330566406
▁of 0.00652313232421875
▁drug 1.4296875
▁delivery 0.01377105712890625
▁techn 0.302978515625
ologies 1.2278556823730469e-05
, 0.3623046875
▁which 0.355224609375
▁enable 2.9453125
▁the 0.91552734375
▁controlled 2.95703125
▁release 0.392578125
▁of 0.042999267578125
▁dru 1.375
gs 1.7523765563964844e-05
▁in 1.66015625
▁the 0.6875
▁body 0.049713134765625
. 0.447021484375
▁These 0.58056640625
▁techn 0.1922607421875
ologies 4.6372413635253906e-05
▁help 4.98046875
▁improve 2.1796875
▁patient 1.421875
▁comp 0.1290283203125
liance 8.440017700195312e-05
▁and 0.9326171875
▁minim 3.486328125
ize 0.0006494522094726562
▁side 0.322021484375
▁effects 0.00399017333984375
, 0.1424560546875
▁leading 1.7138671875
▁to 8.130073547363281e-05
▁better 0.326904296875
▁clin 1.94140625
ical 1.3828277587890625e-05
▁out 0.031646728515625
comes 1.7881393432617188e-06
. 0.375244140625
▁One 3.8671875
▁such 0.83203125
▁technology 0.03118896484375
▁is 0.57275390625
▁Sky 2.796875
e 0.03619384765625
Ph 1.408203125
arma 0.00583648681640625
' 0.023101806640625
s 0.00024378299713134766
▁Ge 8.6484375
o 2.365234375
- 4.63671875
CR 8.03125
ST 7.7734375
M 4.40234375
, 1.494140625
▁an 3.1796875
▁advanced 1.7900390625
▁or 1.8056640625
al 0.03778076171875
▁dos 3.4140625
age 0.0338134765625
▁form 0.0699462890625
▁that 0.15869140625
▁del 1.59375
ivers 0.0011434555053710938
▁dru 0.68994140625
gs 1.33514404296875e-05
▁in 1.509765625
▁a 0.2802734375
▁controlled 0.444580078125
▁manner 0.84716796875
, 1.3037109375
▁ens 3.025390625
uring 2.9087066650390625e-05
▁optimal 2.060546875
▁drug 2.3046875
▁concentration 3.015625
▁over 3.212890625
▁an 1.1240234375
▁extended 0.00942230224609375
▁period 0.035369873046875
▁of 0.84765625
▁time 0.0005908012390136719
. 0.018707275390625
<0x0A> 0.6298828125
Acc 5.16015625
ording 0.0020809173583984375
▁to 0.0004875659942626953
▁Mr 3.287109375
. 0.010833740234375
▁Ha 0.00677490234375
igh 0.0001837015151977539
, 0.005390167236328125
▁Sky 1.46484375
e 0.0001919269561767578
Ph 0.0008006095886230469
arma 6.794929504394531e-05
▁has 3.013671875
▁a 1.53515625
▁robust 1.1064453125
▁product 0.76171875
▁pipeline 0.0235137939453125
▁that 1.1044921875
▁is 1.3388671875
▁expected 1.6171875
▁to 3.3020973205566406e-05
▁drive 0.87646484375
▁growth 0.442138671875
▁in 0.0928955078125
▁the 0.7255859375
▁coming 0.12005615234375
▁years 0.0279083251953125
. 0.0048675537109375
▁The 0.387451171875
▁company 0.053253173828125
▁has 1.802734375
▁several 1.0751953125
▁prom 2.380859375
ising 0.0003006458282470703
▁products 2.01171875
▁in 0.138916015625
▁various 0.9541015625
▁stages 0.012847900390625
▁of 0.0003848075866699219
▁development 0.38037109375
▁and 4.5859375
▁commercial 2.875
ization 0.0071258544921875
. 2.388671875
▁Sky 2.119140625
e 0.0019626617431640625
Ph 0.042999267578125
arma 0.0006098747253417969
' 0.36767578125
s 0.0001239776611328125
▁most 3.7421875
▁anticip 9.28125
ated 3.6716461181640625e-05
▁product 0.175537109375
, 1.5244140625
▁De 6.65234375
po 0.382568359375
M 4.54296875
orph 1.5048828125
ine 0.1741943359375
, 0.2015380859375
▁is 0.08575439453125
▁a 0.34228515625
▁long 0.78173828125
- 0.0006427764892578125
act 0.057769775390625
ing 1.5497207641601562e-05
▁pain 3.45703125
▁relief 1.580078125
▁medic 1.849609375
ation 4.220008850097656e-05
▁designed 3.55078125
▁to 0.2445068359375
▁improve 3.14453125
▁patient 0.386474609375
▁quality 3.53125
▁of 0.0018739700317382812
▁life 0.00011277198791503906
. 0.334228515625
▁The 0.7080078125
▁drug 2.384765625
▁has 1.5205078125
▁received 1.720703125
▁favor 3.48828125
able 3.612041473388672e-05
▁results 2.822265625
▁in 0.275146484375
▁clin 0.2359619140625
ical 2.5153160095214844e-05
▁tri 0.0235443115234375
als 2.86102294921875e-06
▁and 0.11407470703125
▁is 0.054656982421875
▁await 4.0859375
ing 3.933906555175781e-06
▁regul 0.46533203125
atory 1.1205673217773438e-05
▁appro 0.005878448486328125
val 6.556510925292969e-06
, 4.5546875
▁with 0.63623046875
▁market 4.3203125
▁launch 0.55712890625
▁expected 0.51318359375
▁in 0.1539306640625
▁the 1.9111328125
▁near 1.623046875
▁future 0.0028076171875
. 0.0012331008911132812
<0x0A> 0.03533935546875
In 1.19921875
▁addition 0.0421142578125
▁to 0.031646728515625
▁its 0.231689453125
▁internal 2.89453125
▁pipeline 1.490234375
, 0.039154052734375
▁Sky 0.0022983551025390625
e 8.189678192138672e-05
Ph 0.00031113624572753906
arma 2.0265579223632812e-05
▁has 0.31201171875
▁established 1.1552734375
▁strateg 1.255859375
ic 2.682209014892578e-05
▁partners 0.0465087890625
hips 7.37905502319336e-05
▁with 0.0241241455078125
▁major 1.1796875
▁ph 0.0177001953125
arma 4.684925079345703e-05
ce 0.003520965576171875
ut 2.9802322387695312e-06
ical 5.960464477539062e-07
▁companies 0.005985260009765625
▁to 0.88818359375
▁le 2.37890625
verage 1.71661376953125e-05
▁their 3.01171875
▁commercial 3.6015625
▁infrastr 3.08984375
ucture 0.01352691650390625
▁and 0.2249755859375
▁global 3.720703125
▁reach 0.142333984375
. 0.0091094970703125
▁These 0.77197265625
▁partners 0.1090087890625
hips 0.0017805099487304688
▁bring 6.62109375
▁significant 3.29296875
▁re 1.8994140625
venue 0.00482177734375
▁streams 1.306640625
▁through 6.48828125
▁lic 1.0634765625
ens 0.00666046142578125
ing 5.447864532470703e-05
▁de 1.9072265625
als 2.849102020263672e-05
▁and 0.47802734375
▁roy 1.7958984375
alt 5.960464477539062e-07
ies 1.3113021850585938e-06
. 1.00390625
▁An 7.2265625
▁example 0.296142578125
▁of 0.2293701171875
▁this 1.669921875
▁is 0.471923828125
▁Sky 0.6455078125
e 0.0008902549743652344
Ph 0.00923919677734375
arma 0.0006837844848632812
' 0.0027561187744140625
s 6.008148193359375e-05
▁collaboration 1.48046875
▁with 0.0011529922485351562
▁Gla 2.376953125
x 0.00018990039825439453
o 0.0006327629089355469
▁Well 3.265625
come 0.0047760009765625
, 1.0517578125
▁which 0.435791015625
▁has 1.1318359375
▁granted 5.015625
▁the 0.66162109375
▁company 0.016632080078125
▁exclusive 0.49755859375
▁rights 0.556640625
▁to 0.0117340087890625
▁develop 0.76806640625
▁controlled 7.1484375
- 0.319580078125
release 0.006839752197265625
▁versions 1.7265625
▁of 0.00017070770263671875
▁Gla 1.880859375
x 0.0006632804870605469
o 0.0003764629364013672
' 0.6611328125
s 9.989738464355469e-05
▁existing 2.8359375
▁dru 0.84423828125
gs 2.5033950805664062e-06
. 0.1705322265625
▁The 3.0859375
▁agreement 2.498046875
▁not 6.515625
▁only 0.011016845703125
▁divers 4.9453125
ifies 0.007343292236328125
▁Sky 0.09661865234375
e 7.975101470947266e-05
Ph 0.0009732246398925781
arma 0.00010800361633300781
' 0.00015556812286376953
s 2.8252601623535156e-05
▁re 0.70361328125
venue 1.0251998901367188e-05
▁streams 0.3212890625
▁but 0.134765625
▁also 0.00452423095703125
▁provides 1.3720703125
▁the 1.7568359375
▁opportunity 3.75
▁to 0.40234375
▁enh 3.421875
ance 3.933906555175781e-06
▁the 0.398193359375
▁market 2.779296875
ability 3.419921875
▁of 0.0931396484375
▁established 6.671875
▁dru 0.385986328125
gs 1.9073486328125e-06
. 0.462890625
<0x0A> 0.005962371826171875
In 2.892578125
vest 1.8623046875
ors 0.148681640625
▁have 2.498046875
▁taken 0.990234375
▁note 0.5927734375
▁of 0.00341033935546875
▁Sky 0.0792236328125
e 4.076957702636719e-05
Ph 0.0006084442138671875
arma 3.3855438232421875e-05
' 0.0010728836059570312
s 3.2067298889160156e-05
▁impress 2.119140625
ive 2.6226043701171875e-06
▁performance 1.158203125
▁and 0.321533203125
▁growth 1.208984375
▁potential 0.638671875
, 1.0458984375
▁resulting 2.705078125
▁in 2.7418136596679688e-05
▁a 0.447265625
▁sur 2.541015625
ge 0.0026149749755859375
▁in 0.01201629638671875
▁the 0.54833984375
▁company 0.023895263671875
' 0.0003883838653564453
s 8.225440979003906e-06
▁stock 1.70703125
▁value 4.33203125
. 0.1336669921875
▁Sky 2.294921875
e 0.000980377197265625
Ph 0.004718780517578125
arma 4.494190216064453e-05
' 0.400390625
s 9.09566879272461e-05
▁shares 1.4140625
, 4.68359375
▁which 0.66748046875
▁were 0.64111328125
▁trad 0.386474609375
ing 0.0374755859375
▁at 0.07373046875
▁£ 1.970703125
2 1.7880859375
. 0.228515625
7 2.37890625
5 0.73681640625
▁at 1.8330078125
▁the 0.01873779296875
▁beginning 1.1865234375
▁of 0.00016200542449951172
▁ 0.276123046875
1 0.0789794921875
9 2.5391578674316406e-05
9 0.00020134449005126953
7 0.330078125
, 0.0032711029052734375
▁closed 4.3125
▁at 0.0845947265625
▁£ 0.165771484375
1 1.5576171875
0 1.736328125
. 0.058258056640625
4 2.51953125
5 1.6630859375
▁on 0.78271484375
▁the 2.55078125
▁London 0.3798828125
▁Stock 0.0237884521484375
▁Exchange 0.0023365020751953125
▁at 2.6328125
▁the 0.01898193359375
▁end 0.03314208984375
▁of 0.0004086494445800781
▁the 1.681640625
▁year 0.09942626953125
. 0.322021484375
▁This 1.4296875
▁remarkable 3.666015625
▁growth 1.1484375
▁unders 4.90625
c 0.0004506111145019531
ores 3.7670135498046875e-05
▁invest 2.552734375
or 1.1796875
▁confidence 0.00882720947265625
▁in 0.0021190643310546875
▁the 0.2822265625
▁company 0.0031719207763671875
' 0.09747314453125
s 1.2040138244628906e-05
▁future 1.4921875
▁prospect 0.505859375
s 1.5497207641601562e-05
. 0.12249755859375
<0x0A> 0.03271484375
However 4.06640625
, 1.6570091247558594e-05
▁challeng 3.96875
es 0.0011472702026367188
▁still 2.9453125
▁lie 1.564453125
▁ahead 0.003082275390625
▁for 0.363037109375
▁Sky 0.032806396484375
e 3.445148468017578e-05
Ph 0.0002856254577636719
arma 0.00013267993927001953
▁amid 8.0
st 0.94091796875
▁intens 3.6875
ifying 0.036346435546875
▁competition 0.06878662109375
▁and 1.1708984375
▁regul 0.94091796875
atory 6.67572021484375e-06
▁hur 0.6376953125
d 9.5367431640625e-07
les 6.318092346191406e-06
. 0.0843505859375
▁The 0.94580078125
▁ph 3.236328125
arma 0.00010514259338378906
ce 0.0025043487548828125
ut 3.5762786865234375e-07
ical 9.894371032714844e-06
▁industry 0.00995635986328125
▁is 0.137451171875
▁character 2.802734375
ized 0.0006341934204101562
▁by 5.650520324707031e-05
▁fier 2.591796875
ce 0.00040435791015625
▁competition 0.187255859375
, 0.375
▁particularly 3.779296875
▁in 0.0960693359375
▁the 0.059661865234375
▁drug 2.2265625
▁delivery 0.019439697265625
▁segment 1.560546875
. 0.47900390625
▁Sky 1.1083984375
e 0.00014340877532958984
Ph 0.0006117820739746094
arma 0.0001380443572998047
▁faces 1.845703125
▁the 4.7265625
▁constant 6.265625
▁need 5.30078125
▁for 4.078125
▁innov 0.1781005859375
ation 0.08740234375
▁and 0.77099609375
▁different 3.251953125
iation 3.3974647521972656e-05
▁to 0.376708984375
▁stay 2.033203125
▁ahead 0.039459228515625
▁of 0.10174560546875
▁its 0.94140625
▁riv 1.30078125
als 2.86102294921875e-06
. 0.1561279296875
▁Additionally 2.12109375
, 3.600120544433594e-05
▁the 0.69482421875
▁regul 1.203125
atory 7.56978988647461e-05
▁landscape 1.55859375
▁pos 5.48828125
es 1.0967254638671875e-05
▁ris 7.09375
ks 1.2159347534179688e-05
, 1.7900390625
▁with 0.91357421875
▁string 1.4599609375
ent 6.556510925292969e-05
▁appro 0.96337890625
val 9.5367431640625e-07
s 5.48046875
▁processes 0.552734375
▁and 0.39697265625
▁potential 3.345703125
▁del 0.77783203125
ays 1.800060272216797e-05
▁impact 4.12109375
ing 0.00012445449829101562
▁product 1.5458984375
▁launch 0.2802734375
es 0.224365234375
. 0.28173828125
<0x0A> 0.197509765625
Des 0.55322265625
p 1.0728836059570312e-06
ite 4.76837158203125e-07
▁these 0.056121826171875
▁challeng 0.1048583984375
es 1.6570091247558594e-05
, 0.0004677772521972656
▁Sky 0.11053466796875
e 8.130073547363281e-05
Ph 0.00029540061950683594
arma 3.4689903259277344e-05
' 2.798828125
s 3.1828880310058594e-05
▁leadership 2.353515625
▁remains 0.45166015625
▁optim 0.6982421875
istic 7.271766662597656e-06
▁about 0.145263671875
▁the 0.10430908203125
▁company 0.2022705078125
' 0.00035762786865234375
s 2.4318695068359375e-05
▁prospect 1.767578125
s 6.794929504394531e-05
. 0.419189453125
▁With 2.40625
▁a 0.5458984375
▁strong 1.271484375
▁product 0.94140625
▁pipeline 0.09454345703125
, 0.53955078125
▁strateg 0.40771484375
ic 0.0010528564453125
▁partners 0.04107666015625
hips 0.00032901763916015625
, 0.040374755859375
▁and 0.011505126953125
▁a 1.3310546875
▁track 3.630859375
▁record 0.0006437301635742188
▁of 0.0016088485717773438
▁innov 0.9111328125
ation 0.05474853515625
, 0.2452392578125
▁Sky 0.82080078125
e 6.127357482910156e-05
Ph 0.00035071372985839844
arma 0.00011336803436279297
▁is 0.108642578125
▁well 0.5966796875
- 0.0975341796875
position 0.04937744140625
ed 8.702278137207031e-06
▁to 0.0703125
▁deliver 2.537109375
▁strong 5.10546875
▁results 3.53125
▁in 0.467529296875
▁the 0.84814453125
▁coming 0.26220703125
▁year 3.115234375
. 0.272705078125
▁Anal 5.9296875
yst 0.0007877349853515625
s 0.00553131103515625
▁and 2.73828125
▁industry 2.6953125
▁exper 0.1416015625
ts 1.633167266845703e-05
▁share 4.44140625
▁this 0.5419921875
▁optim 0.6630859375
ism 0.048614501953125
, 0.131591796875
▁as 3.75390625
▁they 1.8388671875
▁for 4.265625
ese 0.00026798248291015625
e 2.6941299438476562e-05
▁Sky 3.705078125
e 9.870529174804688e-05
Ph 0.0006375312805175781
arma 5.519390106201172e-05
▁continu 3.375
ing 0.0001627206802368164
▁to 0.95654296875
▁establish 5.3828125
▁itself 0.1947021484375
▁as 0.00130462646484375
▁a 0.0211029052734375
▁key 2.642578125
▁player 0.0012521743774414062
▁in 0.002437591552734375
▁the 0.01238250732421875
▁global 1.07421875
▁drug 0.365966796875
▁delivery 0.0032825469970703125
▁market 0.409423828125
. 0.0491943359375
<0x0A> 0.0921630859375
As 2.86328125
▁Sky 0.84326171875
e 5.841255187988281e-05
Ph 0.0005669593811035156
arma 2.9921531677246094e-05
▁en 7.59375
vis 0.0066070556640625
ions 0.034881591796875
▁a 0.220947265625
▁" 0.193115234375
mag 0.009613037109375
ic 0.006137847900390625
▁year 0.0087432861328125
" 0.007781982421875
▁of 0.318359375
▁growth 0.00959014892578125
▁for 1.3203125
▁its 0.366455078125
▁invest 0.02264404296875
ors 0.0001938343048095703
▁in 0.53515625
▁ 0.0019521713256835938
1 0.0009975433349609375
9 1.239776611328125e-05
9 2.396106719970703e-05
8 0.00026488304138183594
, 0.0027675628662109375
▁the 1.078125
▁company 0.14111328125
' 1.080078125
s 2.9921531677246094e-05
▁achiev 2.498046875
ements 0.0017309188842773438
▁and 0.97412109375
▁potential 1.6005859375
▁put 6.8046875
▁it 0.023773193359375
▁on 1.6669921875
▁a 1.2412109375
▁traject 1.81640625
ory 8.344650268554688e-07
▁of 1.9287109375
▁success 0.40869140625
. 0.1519775390625
▁With 0.353515625
▁its 0.8408203125
▁commit 4.69921875
ment 7.295608520507812e-05
▁to 0.0005879402160644531
▁innov 0.053253173828125
ation 0.022918701171875
▁and 0.298095703125
▁partners 1.712890625
hips 0.06683349609375
, 0.06658935546875
▁Sky 0.089111328125
e 7.259845733642578e-05
Ph 0.0002951622009277344
arma 8.380413055419922e-05
▁continues 5.65625
▁to 0.004428863525390625
▁drive 2.859375
▁adv 3.876953125
anc 0.278564453125
ements 5.817413330078125e-05
▁in 0.007171630859375
▁drug 0.44091796875
▁delivery 0.00978851318359375
, 2.30078125
▁ultimately 3.318359375
▁impro 0.537109375
ving 1.6689300537109375e-06
▁patient 0.12481689453125
▁out 0.450439453125
comes 1.3113021850585938e-06
▁and 0.3779296875
▁generating 5.0625
▁value 2.25390625
▁for 0.001605987548828125
▁its 0.775390625
▁st 1.017578125
ake 1.3113021850585938e-06
hold 1.5974044799804688e-05
ers 8.344650268554688e-07
. 0.0086517333984375
